dc.contributorUniversidade Estadual Paulista (UNESP)
dc.contributorUniversidade de São Paulo (USP)
dc.contributorUniversidade Federal do Rio de Janeiro (UFRJ)
dc.contributorHospital Herrera-Llerandi/AMEDESGUA
dc.date.accessioned2022-04-29T08:30:52Z
dc.date.accessioned2022-12-20T02:48:15Z
dc.date.available2022-04-29T08:30:52Z
dc.date.available2022-12-20T02:48:15Z
dc.date.created2022-04-29T08:30:52Z
dc.date.issued2021-01-01
dc.identifierRheumatology International.
dc.identifier1437-160X
dc.identifier0172-8172
dc.identifierhttp://hdl.handle.net/11449/229187
dc.identifier10.1007/s00296-021-04949-6
dc.identifier2-s2.0-85110858388
dc.identifier.urihttps://repositorioslatinoamericanos.uchile.cl/handle/2250/5409321
dc.description.abstractFocal lymphocytic sialadenitis (FLS), an important diagnostic criterion for Sjögren’s syndrome (SS) diagnosis, can also be observed when assessing minor salivary gland (mSG) biopsies from healthy asymptomatic individuals (non-SS patients). Fifty cases of primary SS (pSS group) and 31 cases of oral reactive lesions (non-SS non-sicca group) containing also typical FLS features, were assessed by morphological and immunohistochemical (CD10, CD23 and Bcl-6) analysis, aiming at the detection of GCs. All pSS cases showed FLS with focus score (FS) ≥ 1. In the non-SS non-sicca group, 12, 10 and 9 cases showed FLS with FS ≥ 1, FLS with FS < 1 and FLS associated with chronic sclerosing sialadenitis with FS < 1, respectively. The morphological analysis revealed similar frequency of GCs in pSS (20%) and non-SS non-sicca group (19%). The area (p = 0.052) and largest diameter (p = 0.245) of GCs were higher in pSS than non-SS non-sicca group. The FS and number of foci were significantly higher in pSS than non-SS non-sicca group with FS < 1. Immunohistochemistry confirmed all morphological findings (GCs showing CD23 and Bcl-6 positivity, with variable CD10 expression) and additionally in 3 and 1 cases of the pSS and non-SS non-sicca group, respectively. Moreover, another 6 and 2 cases of the pSS and non-SS non-sicca group with FS ≥ 1, respectively, showed positivity only for CD23. FLS can also be observed when assessing oral reactive lesions, which showed similar frequency of GCs with those found in pSS patients. Further studies, including functional analysis of lymphocytic populations and GCs in FLS, are encouraged.
dc.languageeng
dc.relationRheumatology International
dc.sourceScopus
dc.subjectEctopic germinal centers
dc.subjectFocal lymphocytic sialadenitis
dc.subjectImmunohistochemistry
dc.subjectNon-Sjögren’s non-sicca patient
dc.subjectOral reactive lesions
dc.subjectSjögren’s syndrome
dc.titleFocal lymphocytic sialadenitis and ectopic germinal centers in oral reactive lesions and primary Sjögren’s syndrome: a comparative study
dc.typeArtículos de revistas


Este ítem pertenece a la siguiente institución